Insmed
INSM
#757
Rank
NZ$57.64 B
Marketcap
NZ$262.77
Share price
20.58%
Change (1 day)
-26.24%
Change (1 year)

Market capitalization of Insmed (INSM)

Market cap: NZ$57.64 Billion

As of November 2026 Insmed has a market cap of NZ$57.64 Billion. This makes Insmed the world's 757th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Insmed from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$57.64 B-12%
2025NZ$65.50 B196.65%
2024NZ$22.08 B214.98%
2023NZ$7.01 B64.44%
2022NZ$4.26 B-9.69%
2021NZ$4.72 B0.44%
2020NZ$4.69 B47.8%
2019NZ$3.17 B110.3%
2018NZ$1.51 B-55.03%
2017NZ$3.36 B184.52%
2016NZ$1.18 B-27.9%
2015NZ$1.63 B66.69%
2014NZ$0.98 B21.46%
2013NZ$0.80 B216.18%
2012NZ$0.25 B163.86%
2011NZ$97.04 M-24.18%
2010NZ$0.12 B-7.28%
2009NZ$0.13 B40.09%
2008NZ$98.53 M-24.95%
2007NZ$0.13 B3.73%
2006NZ$0.12 B-33.99%
2005NZ$0.19 B38.59%
2004NZ$0.13 B-21.13%
2003NZ$0.17 B516.13%
2002NZ$28.47 M-90.6%
2001NZ$0.30 B18%
2000NZ$0.25 B

End of Day market cap according to different sources

On Nov 18th, 2026 the market cap of Insmed was reported to be:

NZ$47.80 Billion
by Nasdaq info icon info icon
NZ$47.80 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
NZ$519.50 B 801.18%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
NZ$375.72 B 551.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$240.12 B 316.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$2.76 B-95.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ$1.37 B-97.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
NZ$1.17 B-97.96%๐Ÿ‡บ๐Ÿ‡ธ USA